Handling and reporting of tumor-containing kidney specimens

Clinics in Laboratory Medicine

Volumn 25, Issue 2, 2005, Pages 417-432

  Che, Mingxin ^a   Grignon, David J ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHROMOPHOBE ADENOMA; FROZEN SECTION; GENE TRANSLOCATION; HEALTH SURVEY; HUMAN; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY TUMOR; MICROMORPHOLOGY; MICROSCOPY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NEPHRECTOMY; PATHOGENESIS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VOLUME;

EID: 17444400414     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2005.01.009     Document Type: Review

References (64)

1. N.K. Janzen, H.L. Kim, and R.A. Figlin Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease Urol Clin N Am 30 2003 843 852
2. Z. Kirkali, and M. Lekili Renal cell carcinoma: new prognostic factors? Curr Opin Urol 13 2003 433 438
3. W.M. Murphy, D.J. Grignon, and E.J. Perlman Tumors of the kidney, bladder, and related urinary structures S.G. Silverberg L.H. Sobin Atlas of tumor pathology, 4th series, fascicle 1 2004 American Registry of Pathology Washington, DC
4. J.N. Eble G. Sauter J.I. Epstein World Health Organization Classification of tumours. pathology and genetics of tumours of the urinary system and male genital organs 2004 IARC Press Lyon (France)
5. I. Frank, M.L. Blute, and J.C. Cheville Solid renal tumors: an analysis of pathological features related to tumor size J Urol 170 2003 2217 2220
6. M.B. Amin, P. Tamboli, and J. Javidan Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases Am J Surg Pathol 26 2002 281 291
7. C.M. Lohse, M.L. Blute, and H. Zincke Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients Am J Clin Pathol 118 2002 877 886
8. M. Peyromaure, V. Misrai, and N. Thiounn Chromophobe renal cell carcinoma: analysis of 61 cases Cancer 100 2004 1406 1410
9. T. Onishi, Y. Oishi, and S. Yanada Prognostic implications of histological features in patients with chromophobe cell renal carcinoma BJU Int 90 2002 529 532
10. A.A. Renshaw, E.P. Henske, and K.R. Loughlin Aggressive variants of chromophobe renal cell carcinoma Cancer 78 1996 1756 1761
11. B. Delahunt, J.N. Eble, and M.R. McCredie Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases Hum Pathol 32 2001 590 595
12. B. Delahunt, and J.N. Eble Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors Mod Pathol 10 1997 537 544
13. X. Leroy, L. Zini, and E. Leteurtre Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes Mod Pathol 15 2002 1126 1130
14. D. Chao, A. Zisman, and A.J. Pantuck Collecting duct renal cell carcinoma: clinical study of a rare tumor J Urol 167 2002 71 74
15. S.M. Kennedy, M.J. Merino, and W.M. Linehan Collecting duct carcinoma of the kidney Hum Pathol 21 1990 449 456
16. R.A. Avery, J.E. Harris, and C.J. Davis Jr. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor Cancer 78 1996 128 132
17. R.S. Figenshau, J.W. Basler, and J.H. Ritter Renal medullary carcinoma J Urol 159 1998 711 713
18. J.W. Said, G. Thomas, and A. Zisman Kidney pathology: current classification of renal cell carcinoma Curr Urol Rep 3 2002 25 30
19. B.M. Mian, N. Bhadkamkar, and J.W. Slaton Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma J Urol 167 2002 65 70
20. J.C. Yang, L. Haworth, and R.M. Sherry A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 2003 427 434
21. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655 663
22. K.H. Tsui, O. Shvarts, and R.B. Smith Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria J Urol 163 2000 1090 1095 [quiz 1295]
23. V. Ficarra, R. Righetti, and G. Martignoni Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases Urol Int 67 2001 130 134
24. S. Baltaci, D. Orhan, and S. Soyupek Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma J Urol 164 2000 36 39
25. P. Guinan, L.H. Sobin, and F. Algaba TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 1997 992 993
26. B. Delahunt, J.M. Kittelson, and M.R. McCredie Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters Cancer 94 2002 658 664
27. A. Zucchi, L. Mearini, and E. Mearini Stage pT1 renal cell carcinoma: review of the prognostic significance of size Urol Int 70 2003 47 50
28. B. Ljungberg, F.I. Alamdari, and T. Rasmuson Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy BJU Int 84 1999 405 411
29. K.S. Hafez, A.C. Novick, and S.C. Campbell Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma J Urol 157 1997 2067 2070
30. F.L. Greene D.L. Page I.D. Fleming AJCC cancer staging manual 6th edition 2002 Springer-Verlag New York
31. V. Ficarra, T. Prayer-Galetti, and G. Novara Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma Urology 63 2004 235 239 [discussion 239-40]
32. J.M. Elmore, K.T. Kadesky, and K.S. Koeneman Reassessment of the 1997 TNM classification system for renal cell carcinoma Cancer 98 2003 2329 2334
33. J. Javidan, H.J. Stricker, and P. Tamboli Prognostic significance of the 1997 TNM classification of renal cell carcinoma J Urol 162 1999 1277 1281
34. A.J. Stephenson, M.P. Chetner, and K. Rourke Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy J Urol 172 2004 58 62
35. D.A. Levy, J.W. Slaton, and D.A. Swanson Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma J Urol 159 1998 1163 1167
36. C. Wittekind, C.C. Compton, and F.L. Greene TNM residual tumor classification revisited Cancer 94 2002 2511 2516
37. D.F. Griffiths, A. Verghese, and A. Golash Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma BJU Int 90 2002 26 31
38. P.D. Goncalves, M. Srougi, and M.F. Dall'lio Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter J Urol 172 2004 470 474
39. I. Frank, M.L. Blute, and J.C. Cheville An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol 168 2002 2395 2400
40. A. Zisman, A.J. Pantuck, and F. Dorey Improved prognostication of renal cell carcinoma using an integrated staging system J Clin Oncol 19 2001 1649 1657
41. A. Zisman, A.J. Pantuck, and J. Wieder Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559 4566
42. K.R. Han, I. Bleumer, and A.J. Pantuck Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population J Urol 170 2003 2221 2224
43. J.J. Patard, H.L. Kim, and J.S. Lam Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study J Clin Oncol 22 2004 3316 3322
44. B.C. Leibovich, M.L. Blute, and J.C. Cheville Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials Cancer 97 2003 1663 1671
45. I. Frank, M.L. Blute, and J.C. Cheville A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma J Urol 170 2003 2225 2232
46. B.D. Curti Renal cell carcinoma JAMA 292 2004 97 100
47. T. Saika, Y. Ono, and R. Hattori Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinoma Urology 62 2003 1018 1023
48. S.C. Abreu, and I.S. Gill Renal cell carcinoma: modern surgical approach Curr Opin Urol 13 2003 439 444
49. I.S. Gill, A.M. Meraney, and D.K. Schweizer Laparoscopic radical nephrectomy in 100 patients: a single center experience from the United States Cancer 92 2001 1843 1855
50. S.E. Pautler, S.M. Hewitt, and W.M. Linehan Specimen morcellation after laparoscopic radical nephrectomy: confirmation of histologic diagnosis using needle biopsy J Endourol 16 2002 89 92
51. H. Van Poppel Partial nephrectomy: the standard approach for small renal cell carcinoma? Curr Opin Urol 13 2003 431 432
52. W.K. Lau, M.L. Blute, and A.L. Weaver Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney Mayo Clin Proc 75 2000 1236 1242
53. N.Y. Piper, J.T. Bishoff, and C. Magee Is a 1-CM margin necessary during nephron-sparing surgery for renal cell carcinoma? Urology 58 2001 849 852
54. S.E. Sutherland, M.I. Resnick, and G.T. MacLennan Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol 167 2002 61 64
55. M.R. Licht, and A.C. Novick Nephron sparing surgery for renal cell carcinoma J Urol 149 1993 1 7
56. A.F. Fergany, K.S. Hafez, and A.C. Novick Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup J Urol 163 2000 442 445
57. K.G. Krejci, M.L. Blute, and J.C. Cheville Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome Urology 62 2003 641 646
58. J.J. Patard, O. Shvarts, and J.S. Lam Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience J Urol 171 2004 2181 2185 [quiz 2435]
59. M.E. Allaf, S.B. Bhayani, and C. Rogers Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome J Urol 172 2004 871 873
60. J.T. Rabban, M.V. Meng, and B. Yeh Kidney morcellation in laparoscopic nephrectomy for tumor: recommendations for specimen sampling and pathologic tumor staging Am J Surg Pathol 25 2001 1158 1166
61. M.G. Harisinghani, M.M. Maher, and D.A. Gervais Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol 180 2003 755 758
62. B.J. Wood, M.A. Khan, and F. McGovern Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management J Urol 161 1999 1470 1474
63. E.K. Lang, R.J. Macchia, and B. Gayle CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management Eur Radiol 12 2002 2518 2524
64. C.B. Dechet, T. Sebo, and G. Farrow Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults J Urol 162 1999 1282 1284